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Abstract
The 9-azabicyclo[3.3.1]nonane ring system is present in several insect- and plant-derived alkaloids. (−)-Adaline (1) and (+)-eupho-
coccinine (2), found in secretions of Coccinelid beetles, and (+)-N-methyleuphococcinine (3), isolated from the Colorado blue
spruce Picea pungens, are members of this alkaloid family. Their unique bicyclic system with a quaternary stereocenter, and the po-
tent biological activity exerted by these homotropane alkaloids, make them attractive synthetic targets. This work aims briefly to
review the chemical ecology of Adalia bipunctata and the recent methodologies to obtain adaline (1), euphococcinine (2), and
N-methyleuphococcinine (3).
Introduction
Coccinellid beetles contain a variety of defensive alkaloids that
makes them unpleasant for various predators [1]. Over 50 alka-
loids have been characterized from ladybirds until now, includ-
ing perhydroazaphenalenes, aliphatic and aromatic amines,
piperidines, pyrrolidines, azamacrolides, dimeric alkaloids and
homotropanes [2]. The majority of these alkaloids have an
endogenous origin. In a dangerous situation or predator attack,
the beetles can emit droplets of hemolymph. This substance
comes from the tibiofemoral joints situated in their legs, a
mechanism known as reflex bleeding. This situation brings the
alkaloids to the surface as an early warning signal to the
attacker.
The fluid toxicity and bitterness, added to the characteristic
odor of these insects, have been regarded as a protection against
insect or vertebrate predators [3]. Bicyclic ring systems bearing
a nitrogen bridge are often found in nature [4-6]. Typical exam-
ples include cocaine, atropine, and scopolamine. These com-
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pounds are 8-azabicyclo[3.2.1]octane derivatives and belong to
a large class of natural products known as tropane alkaloids
[7-9]. In contrast to tropane alkaloids, the higher homologs
homotropanes (9-azabicyclononanes) are less common in
nature, but not less important. They possess biological proper-
ties, such as nicotinic acetylcholine receptor (nAChR) ligand
[10,11], CNS (central nervous system) activity [12,13], and
chemical defense [14-16]. Structurally, homotropane alkaloids
have different skeletons including [3.3.1], [4.2.1] and [3.2.2]
(Figure 1).
Figure 1: Homotropane (azabicyclononane) systems.
The homotropane alkaloid (−)-adaline (1) was isolated from
ladybird Adalia bipunctata [17] and Cryptolaemus moutrouzieri
secretions [18]. A methyl analog, (+)-euphococcinine (2), has
been found in vegetable and animal kingdoms. The compound
was first isolated from the Australian coastal plant Euphorbia
atoto [19], and it is also present in the defense secretion of lady-
birds Cryptolaemus montrouzieri [18] and Epilachna varivestis
[16]. Also, (+)-N-methyleuphococcinine (3) has been identified
as a trace homotropane alkaloid isolated from the spruce tree
Picea pungens [20] (Figure 2).
Figure 2: Alkaloids (−)-adaline (1), (+)-euphococcinine (2) and (+)-N-
methyleuphococcinine (3).
The small amount of these homotropane alkaloids isolated from
ladybirds (e.g., for (−)-adaline, 35 mg from 800 specimens)
emphasizes the desirability of practical syntheses for further bi-
ological studies [17]. Besides, the attractive structural features
of (−)-adaline (1) and its relatives have provided new opportu-
nities to develop synthetic strategies [21-23]. Structurally, it has
an unsymmetrical bicyclic arrangement, incorporating a second-
ary amine and bearing a quaternary center. Since the pioneering
Tursch’s work [24], a variety of approaches to obtain these
alkaloids have been described by many research groups [25-28].
King and Meinwald earlier reviewed some of these syntheses in
an elegant approach to coccinellids chemistry and biology [29].
The current work reports a brief description of the chemical
ecology of Adalia bipunctata. Then we present an up to date
review of the synthetic strategies to obtain alkaloids 1–3, in-
cluding racemic and asymmetric syntheses, aiming to achieve a
deep and comprehensive understanding of the area. It also
provides suggestions for future studies on homotropane alka-
loids. The present review is chronologically organized, encom-
passing all synthetic works published in the last 25 years.
Review
Chemical ecology of Adalia bipunctata
Individuals of Adalia bipunctata species (2-spot ladybird)
display aposematic coloration reinforced by the production and
release of remarkable amounts of reflex-fluid, in response to
predator attack [29-32]. This liquid can be over 20% of the
body weight, in some cases. The amount of the toxic alkaloid
(−)-adaline varies between 5–6% of the wet weight of reflex
fluid in 2-spot ladybirds. However, the concentration of
(−)-adaline found in A. bipunctata is about 6–8 times greater
than the concentration of coccineline found in C. septempunc-
tata [31]. This difference may occur to compensate (−)-adaline's
lower toxicity than coccineline. Biosynthetic studies carried out
by Laurent et al. [33,34] showed that adults of A. bipunctata in-
cubated in vitro with [14,14,14-3H3]myristic acid incorporated
this precursor in (−)-adaline, supporting fatty acid origin for this
alkaloid.
Reflex bleeding is costly due to energy expended in chemical
synthesis and fluid loss. Therefore, it is only deployed when
other strategies have failed, and the ladybird is in severe danger
[35,36]. A massive discrepancy in (−)-adaline concentration and
reflex-fluid amount can be found within beetles. It suggests that
internal aspects such as genetic factors may determine how
much energy is invested in chemical defense [30]. Paul et al.
[37] demonstrated that parental effects could play a crucial role
in determining the color and toxin [(−)-adaline] content of
A. bipunctata eggs, once the maternal and paternal aposematic
phenotype had the most significant effect on egg traits if com-
pared to the maternal responses to offspring predators. Thus, the
phenotype can also contribute to the aposematic signal varia-
tion in a ladybird’s early life, in addition to genetic factors. In
this way, it should consequently lead to success in the species’
survival.
Recent elegant studies by Steele et al. [38,39] provide an insight
into the impact of pathogen infection upon production of the
alkaloid 1 in A. bipunctata. When A. bipunctata was infected by
the microsporidian pathogen Nosema adaliae, larval develop-
Beilstein J. Org. Chem. 2021, 17, 28–41.
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Scheme 1: Synthetic strategies before 1995.
ment was significantly delayed. At elevated temperatures,
developmental delays caused by infection were reduced, spore
counts and infection decreased, and there was an increase in the
content of 1 [38]. In a second study, the authors evaluated the
effects of the N. adaliae infection and food availability on pro-
duction of 1 [39]. Infected A. bipunctata were shown to produce
more 1 than uninfected adults. Furthermore, the daily fed adults
produced more of 1 than those adults that were fed irregularly,
and uninfected adults that fed irregularly had the lowest content
of 1. The infection load of adults was significantly increased in
beetles that were fed irregularly. Taken together, these results
suggest that 1 may provide A. bipunctata with chemical defence
against pathogen challenge.
Syntheses
A concise overview of the strategies towards the
synthesis of homotropane alkaloids: before 1995
As previously reported by King and Meinwald [29], synthetic
strategies have been designed and employed in the synthesis of
adaline (1) and euphococcinine (2), before 1995. In brief, 1 and
2 were synthesized in both racemic and asymmetric forms. Key
(homotropane construction) steps included: i) inter and intramo-
lecular Mannich reaction; ii) double Michael addition in the
cyclooctadienone derivative; and iii) intramolecular 1,3-dipolar
cycloaddition. As shown in Scheme 1, the azabicyclononane
ring is an interesting target for strategies based on the Mannich
reaction. This methodology is mostly used in some cases, with
few steps, and from commercially available reagents.
Holmes synthesis – 1995
Davison and Holmes prepared racemic (±)-adaline (1) and
(±)-euphococcinine (2). The key step in the synthesis involved
the intramolecular dipolar cycloaddition to produce tricyclic
isoxazolidines [40].
The synthesis started from 5-hexyn-1-ol (4, Scheme 2). The
alcohol was treated with dihydropyran followed by alkylation
using butyllithium and then, acetal deprotection, providing the
alcohol 5 as a key starting compound for the (±)-adaline (1). Al-
ternatively, the (±)-euphococcinine precursor 6 was prepared
from 4, via deprotonation, silylation, and finally, silyl ether
cleavage. Swern oxidation of alcohols 5 and 6 gave aldehydes 7
Beilstein J. Org. Chem. 2021, 17, 28–41.
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Scheme 2: Synthesis (±)-adaline (1) and (±)-euphococcinine (2). Reagents and conditions: i) 1. dihydropyran, amberlyst-15 resin; 2. n-BuLi, TMEDA,
then BuBr, 60% over 2 steps; ii) amberlyst-15 resin, MeOH; iii) 1. n-BuLi; 2. TMSCl, 3. HCl aqueous, 76% over 3 steps; iv) oxalyl chloride, DMSO,
Et3N, 80–90%; v) CH2=CHCH2MgBr, Et2O, 70–81%; vi) 1. CrO3, HOAc; 2. NH2OH·HCl, Py–EtOH, 58–66%; vii) NaCNBH3, MeOH, pH 3–4; viii) tolu-
ene, reflux, 9 h, 71–76%; ix) Raney-Ni, H2, 90 min, 93–96%; x) PCC, CH2Cl2, 70–72%.
and 8, treated with allylmagnesium bromide, to generate sec-
ondary alcohols 9 and 10. These alcohols were converted to
oximes 11 and 12 via oxidation with chromium trioxide fol-
lowed by treatment with hydroxylamine hydrochloride. 11 and
12 were reduced by sodium cyanoborohydride and the resulting
hydroxylamines were converted in nitrones, after heating under
reflux. These nitrones were not isolated but subjected to intra-
molecular dipolar cycloaddition to give racemic adducts (±)-13
and (±)-14, with good yields. The synthesis was complete ac-
cording to the procedure used by Gössinger [25]. Thus, the re-
ductive cleavage of the N–O bond in the presence
of Raney-Ni and hydrogen provided the bicyclic alcohols
(±)-15 and (±)-16, which were oxidized with pyridinium
chlorochromate giving the alkaloids (±)-adaline (1) and
(±)-euphococcinine (2), respectively.
The synthetic route performed by the authors allowed accessing
both racemic homotropane alkaloids in 8 steps, starting from
alcohol 5 (or 6) in 15.0–25.3% overall yields. A relevant
consideration in Holmes’s synthesis is: the nitrone is the same
common intermediate as Gössinger’s [25], which is cyclized to
form the tricyclic adducts. While the Gössinger route started
from the cyclic 1-hydroxypiperidine, Holmes performed in situ
cyclization to prepare the nitrone.
Murahashi synthesis – 2000
Starting from secondary amines, Murahashi et al. developed a
method for preparing homochiral β-sulfinyl nitrones [41]. Ac-
cordingly, (+)-euphococcinine (2) was prepared through allyla-
tion followed by the 1,3-dipolar cycloaddition of β-sulfinyl
nitrone 20 derived from piperidine (17). The synthetic se-
quence performed by the authors is described in Scheme 3. Oxi-
dation of 17 in the presence of hydrogen peroxide, catalyzed by
selenium dioxide provided tetrahydropyridine N-oxide 18 in
88% yield. 18 was treated with (R)-p-tolylsulfinylmethyl-
lithium 25 in THF at −78 °C to provide β-sulfinyl hydroxyl-
amine 19 in a diastereoisomeric ratio of 67:33 in 52% yield.
Oxidation of 19 to nitrone 20 occurred chemoselectivelly
through treatment with a solution of hydrogen peroxide in
3 mol % of 5-ethyluminiflavin perchlorate (FIEt+.ClO4) as a
catalyst in 55% yield. The reaction of β-sulfinyl nitrone 20 with
allylmagnesium bromide in the presence of AlCl3 provided a
mixture of allylpiperidines (+)-21a and its isomer (+)-21b with
54% and 6% yield, respectively. The treatment of (+)-21a with
nickel(III) oxide followed by dipolar cycloaddition of the result-
ing nitrone 22a, furnished the azatricyclo[3.3.1.1]decane (+)-
23a in 54% yield. Treatment of (+)-23a with Raney nickel
resulted in the cleavage of the sulfinyl group and the N–O bond,
providing the bicyclic alcohol 24, which was oxidized with
PCC to give (+)-euphococcinine (2). The same protocol was
applied to (+)-21b, furnishing the tricyclic adduct (+)-23b, a
precursor to (−)-adaline (1).
This methodology, based on the synthesis of optically active
β-sulfinyl nitrones, was proved to be efficient in the synthesis of
(+)-euphococcinine (2) in 7 steps from piperidine (17), in an
Beilstein J. Org. Chem. 2021, 17, 28–41.
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Scheme 3: Synthesis (+)-euphococcinine (2). Reagents and conditions: i) H2O2, SeO2 (cat), acetone, rt, 88%; ii) 25, THF, −78 °C, 52% (67:33 dia-
stereomeric mixture); iii) H2O2, FIEt+.ClO4 (cat.), MeOH, 0 °C, 55%; iv) AlCl3, CH2=CHCH2MgBr, THF, −78 °C, 54%; v) Ni2O3, CHCl3, rt, 54%;
vi) Raney-Ni (W-2), H2O, 30 °C, 95%; vii) PCC, CH2Cl2, rt, 30%.
overall yield of 2.1%. Specific rotation for (+)-2 was
[α]D24 +7.43 (c 0.350, MeOH); {lit. [α]D +7.5 (c 2.0, MeOH),
[26]}. The (−)-adaline precursor (+)-23b was also accessed
from 17 in 5 steps, in an overall yield of 7.3%. Inspired by
Gössinger’s work, Murahashi et al. prepared a nitrone from a
cyclic amine. However, the route was improved by the intro-
duction of a chiral auxiliary. Despite having a common interme-
diate, Murahashi's strategy differed from Gössinger's and
Holmes' syntheses by being an asymmetric version.
Meyers synthesis – 2000
Mechelke and Meyers prepared (+)-euphococcinine (2) from
the bicyclic thiolactam 26 [42]. The strategy was based on an
intramolecular Mannich reaction that occurred in intermediate
31 (Scheme 4). Thus, thiolactam 26 was quantitatively con-
verted to lactam 27, using the Belleau's reagent [43]. 27 was
treated with Weinreb amide 33, prepared from commercially
available bromoacetyl bromide [44] to provide the intermediate
thioiminium salt, which was heated under the reflux of triethyl-
amine and trimethyl phosphite, providing compound 28 in 69%
yield.
The catalytic hydrogenation of 28 occurred in platinum (H2,
Pt/C) under a pressure of 60 psi of hydrogen (about 4 atm), re-
sulting in amide 29 in 96% yield. This hydrogenation occurred
with high stereoselectivity producing a single diastereoisomer
of 29. Then, the amide was treated with methyllithium at
−78 °C to provide ketone 30 in 85% yield. Subsequently, the
intramolecular Mannich reaction was carried out, leading to the
desired alkaloid, via precursor 32. Ketone 30 was then dis-
solved in acetic acid/ethanol 1:1 and treated with ten equiva-
lents of ammonium acetate, stirred overnight at a temperature of
75 °C. Work-up followed by chromatographic column purifica-
tion of the reaction mixture furnished (+)-euphococcinine (2) in
91% yield. This single step procedure from 30 not only led to
the formation of the bicyclic system but also resulted in the loss
of the chiral auxiliary, providing (+)-euphococcinine (2).
Meyer's approach led to (+)-euphococcinine (2) in 5 steps from
lactam 26 in an overall yield of 51.2%. The spectral analysis
(1H and 13C NMR, IR, MS) was identical to that of the natural
product [28]. The specific rotation [α]D of +5.7 was also com-
patible with that found in the literature {lit. [α]D +6
(c 2.0, MeOH), [19]}. Finally, the synthetic sample obtained by
the authors when treated with (S)–Mosher's acid chloride was
converted entirely to a Mosher amide, confirming to be a sam-
ple with a high level of enantiomeric purity. As in Murahashi’s
synthesis, Meyers also utilized a chiral auxiliary for asym-
metric induction. Nonetheless, this method differed from Mura-
hashi's by presenting a diastereoselective intramolecular
Mannich cyclization to form the desired homotropane.
Ikeda synthesis – 2002
Ikeda et al. prepared azabicycle (±)-42, a protected form of
(±)-euphococcinine (2) [45]. The author’s method focused on
the radical reaction of 2-(but-3-ynyl)piperidine (±)-34 mediated
Beilstein J. Org. Chem. 2021, 17, 28–41.
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Scheme 4: Synthesis (+)-euphococcinine (2). Reagents and conditions: i) 2,4-bis(4-phenoxyphenyl)-1,3-dithia-2,4-diphosphetane 2,4-disulfide
(Belleau’s reagent), 100%; ii) 33, triethylamine, trimethyl phosphite, reflux, 69%; iii) H2 (60 psi), Pt/C, Na2CO3, Et2OAc, EtOAc, 96%; iv) methyllithium,
−78 °C, 85%; v) HOAc/EtOH 1:1, ammonium acetate, 75 °C, overnight, 91%.
by Bu3SnH. This "6-exo-dig" cyclization occurred in a regiose-
lective way to provide the 9-azabicyclo[3.3.1]nonane system
observed in (±)-35.
The precursor (±)-34 was prepared from N-boc-pipecolinate,
following a methodology previously described by the authors
[46]. The radical Bu3SnH-mediated cyclization of (±)-34,
occurred efficiently to provide (±)-35 with 95% yield in a 1:1
diastereoisomeric mixture, converted to ketone (±)-37 via meth-
ylene derivative (±)-36, in 63% over two steps (Scheme 5). Ke-
tone (±)-37 was converted to alkenyl triflate (±)-38 after treat-
ment with LDA at −78 °C, followed by the Comins reagent
[47]. (±)-38 was subjected to palladium-catalyzed hydrogena-
tion conditions to afford alkene (±)-39. Hydroboration of (±)-39
with the borane–THF complex followed by oxidation of the ob-
tained intermediate led to the mixture of alcohols (±)-40 +
(±)-41 with yields of 31% and 39%, respectively. The 1H NMR
spectrum confirmed the structure and stereochemistry of
alcohol (±)-41, where the axial proton in position 3 appears
in δ 4.62 as a triplet of triplets, having coupling constants
11.0 and 6.4 Hz. Oxidation of (±)-41 with the TPAP-NMO
system produced ketone (±)-42, a potential precursor to
(±)-euphococcinine (2).
Although being racemic, Ikeda's synthesis employed an innova-
tive “6-exo-dig” cyclization to achieve the azabicyclic system.
The route accomplished by Ikeda et  al .  led to the
(±)-euphococcinine Bz-protected (±)-42 in 7 steps from the pre-
cursor 2-(but-3-ynyl)piperidine (±)-34, in an overall yield of
14.3%. The radical translocation and 6-exo-dig cyclization
developed by the authors conferred an excellent methodology to
obtain the 9-azabicyclo[3.3.1]nonane ring present in
(±)-euphococcinine (2).
Kibayashi synthesis – 2002
Kibayashi et al. performed the enantioselective synthesis of
(−)-adaline (1). Their approach had as key steps SN2-type
alkynylation, activated by lithium ion in a tricyclic N,O-acetal
(−)-46, and an olefin metathesis (RCM) of a dialkenylpiperi-
dine (−)-50 for the construction of an azabicyclononane system
[48]. The synthetic sequence described by the authors is shown
in Scheme 6. The lactam present in 43 was opened by treat-
ment with LiH2NBH3 in THF at 40 °C to provide amino alcohol
(−)-44 in 88% yield. This amino alcohol underwent cyclization
through a one-pot process in the presence of TPAP-NMO,
which involved oxidation in generated aldehyde 45, followed
by dehydrocondensation leading to N,O-tricyclic acetal (−)-46
in 80% yield. After the treatment of (−)-46 with the lithium
acetylide ethylenediamine complex in THF, a nucleophilic
alkynylation occurred, with a reversal of configuration in the
reaction center. Then, removal of the 1-(2-hydroxyphenyl)ethyl
group via cleavage of the C–N bond, leading to (6S)-
ethynylpiperidine (−)-48, in 88% yield, as a single diastereoiso-
mer. Then, (−)-48 was treated with trimethyl orthoformate to
provide formamide (−)-49, being converted to cis-2,6-dialkenyl-
formamide (−)-50 by treatment with the Lindlar catalyst. (−)-50
Beilstein J. Org. Chem. 2021, 17, 28–41.
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Scheme 5: Synthesis of (±)-euphococcinine precursor (±)-42. Reagents and conditions: i) Bu3SnH, AIBN, toluene, reflux, 95%; ii) CF3CO2H, CH2Cl2,
89%; iii) O3, CH2Cl2, 78 °C, then PPh3, 71%; iv) LDA, THF, −78 °C; then Comins’ reagent, 63%; v) Me2NHBH3, cat. Pd(PPh3)4, K2CO3, MeCN,
40 °C, 97%; vi) BH3.THF, then aq NaOH, H2O2, 31% (for (±)-40) and 39% (for (±)-41); vii) TPAP, NMO, 4 Å MS, CH2Cl2, 100%.
Scheme 6: Synthesis of (−)-adaline (1). Reagents and conditions: i) LiH2NBH3, THF, 40 °C, 88%; ii) TPAP, NMO, MeCN, 4A MS, rt, 80%;
iii) HC≡CLi.H2NCH2CH2NH2 (5 equiv), THF, 40 °C, 88%; iv) HCl/MeOH, then HC(OMe)3, 93%; v) Lindlar catalyst, H2, MeOH, 92%; vi) Grubbs cata-
lyst 57 (0.15 equiv), benzene, 50 °C, 99%; vii) OsO4, NMO, MeCN/H2O, 97%; viii) TBDMSOTf, Et3N, CH2Cl2, 98%; ix) 1. CS2, NaH, MeI, THF; 2.
AIBN, Bu3SnH, benzene, reflux, 82% over two steps; x) 1. TBAF, THF; 2. Li.H2NCH2CH2NH2, 90% over two steps; xi) PCC, CH2Cl2, 77%.
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Scheme 7: Synthesis of (−)-adaline (1) and (−)-euphococcinine (2). Reagents and conditions: i) 1. BuLi, t-BuOK, TMEDA, pentane, −78 °C to
−20 °C; 2. RI, THF; 3. H3O+; 44% (R = n-C5H11) and 61% (R = CH3) over three steps; ii) 64, (S)-BINOL-TiIV[OCH(CF3)2]2 (5 mol %), PhCF3, −20 °C,
84% (97% ee, R = n-C5H11) and 94% (90% ee, R = CH3); iii) DIAD, Ph3P, NH3, THF, 81% (R = n-C5H11) and 74% (R = CH3); iv) Ph3P, Et2O, 20 °C,
77% (R = n-C5H11) and 68% (R = CH3); v) 1. CF3SO3H (1.1 equiv), toluene, 0 °C; 2. Bu3SnF (1.2 equiv), toluene, 81% (R = n-C5H11) and 74%
(R = CH3); vi) OsO4 (3 mol %), KIO4, THF/H2O 3:1, 64% (R = n-C5H11) and 71% (R = CH3).
underwent a ring-closing metathesis efficiently in the presence
of the second generation Grubbs catalyst 57 in 99% yield. The
azabicyclic system (+)-51 underwent dihydroxylation with the
OsO4-NMO system to form diol (+)-52 as the only product in
97% yield. Diol (+)-52 was regioselectively protected in the
presence of tert-butyldimethylsilane triflate, and triethylamine
providing a mixture of monoprotected diols (−)-53 and 54 in a
10:1 ratio for the least sterically hindered alcohol in 98% yield.
After chromatographic separation, (−)-53 underwent radical-in-
duced Barton–McCombie deoxygenation (AIBN, Bu3SnH) to
form (−)-55 in 82% yield. The double deprotection of (−)-55
occurred by removing the TBDMS and formyl (CHO) groups
via treatment with TBAF in dry THF and lithium–ethylenedi-
amine complex, respectively. Finally, the resulting alcohol
(+)-56 was oxidized in the presence of PCC to provide
(−)-adaline (1).
In this work, the quaternary center was successfully generated
before the key cyclization step. It was also the first example of
olefin metathesis in (−)-adaline (1) synthesis. Kibayashi's ap-
proach consisted of 13 steps in an overall yield of about 28.3%
from precursor 43, previously used by the authors in the synthe-
sis of (−)-adalinine [49]. The spectral data (1H NMR, 13C
NMR, MS) were identical to those of the natural product, and
the specific rotation [α]D28 −11.4 (c 0.7, CHCl3) comparable to
that found in the literature {[α]D20 −13 (CHCl3), [17]}.
Yu synthesis – 2009
Yu et al. prepared (−)-adaline (1) and the nonnatural enantio-
mer (−)-euphococcinine (2) in a 6-step sequence from 3,4-
dihydro-2-ethoxy-2H-pyran (58) [50].
Treatment of 58 with a mixture of butyllithium and potassium
tert-butoxide in the presence of TMEDA and pentane, followed
by reaction with the corresponding alkyl iodides in THF, and
finally, acidic cleavage of the generated acetal provided alde-
hydes 59a and 59b (Scheme 7). The key step in this synthesis
was the allylic transfer, conducted by the dropwise addition of
64 in PhCF3 at −20 °C to a mixture of 59a and 59b and the
chiral catalyst S-BINOL-TiIV [OCH(CF3)2]2 providing alco-
hols 60a and 60b, after 12 h at −20 ºC. In addition to the good
yields in this step, both intermediates were obtained with excel-
lent enantiomeric excesses (97% for R = n-C5H11 and 90% for
R = CH3).
Compounds 60a and 60b were converted to azido ketones 61a
and 61b by Mitsunobu reaction, and then these azido ketones
underwent cyclization to furnish tetrahydropyridines 62a and
62b after treatment with Ph3P at 20 °C in diethyl ether. 62a and
62b were converted to 63a and 63b through an intramolecular
allylic transfer reaction. After several attempts to perform
this cyclization, the best conditions found were by using
1.1 equivalents of trifluoromethanesulfonic acid in toluene.
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36
Scheme 8: Synthesis of (−)-adaline (1). Reagents and conditions: i) Ref. [52]; ii) Et3N, TBDMSOTf, CH2Cl2, 0 °C to −78 °C, then valeraldehyde,
TiCl4, CH2Cl2, 70%, 97.3% ee; iii) 1. DMAP, Et3N, MsCl, CH2Cl2; 2. DBU, CH2Cl2, 70% over two steps; iv) CH2=CHCH2MgCl, THF; v) HCl (4.0 M in
dioxane), CH2Cl2, 78% over two steps; vi) PdCl2, CuCl, DMF/H2O (20:1), 23 °C, 93%; vii) KOSiMe3, 23 °C, 35 min; viii) NOPF6, DME, 80% over two
steps; ix) 2-butanone ethylene acetal, cat. (CH2OH)2, BF3·Et2O, 85%; x) 1. Luche reduction, 98%; 2. a) NaH; b) CS2, c) MeI, 88%; 3. Bu3SnH, AIBN,
heat, 75%; xi) 1. cat. Pd(MeCN)2Cl2, wet acetone, 95%; 2. H2, Pd-C, 90%.
After 5 minutes, 1.2 equiv of tributyltin fluoride was added
to intermediate A, and at the end of the process, 63a and
63b were obtained after chromatographic purification with 81%
yield for 63a and 74% yield for 63b. Finally, the alkenes were
oxidized in the presence of osmium tetroxide and potassium
periodate, to provide (−)-adaline (1) and (−)-euphococcinine
(2).
Originally, Yu et al. synthesized (−)-adaline (1) with good
yields and high enantiomeric excess using catalytic asymmetric
allylation from commercially available 58. Additionally, intra-
molecular allylic transfer led to the enatiopure azabicycles. This
6-step sequence was successfully completed and (−)-adaline (1)
and (−)-euphococcinine (2) were prepared in overall yields of
11.9% and 15.2%, respectively. Specific rotation measured for
(−)-adaline (1) was [α]D20 −12.2 (c 1.1, CHCl3); {lit. [α]D20
−11 (c 2, CHCl3), [17]} and for (−)-euphococcinine (2) was
[α]20D −6.1 (c 1.3, MeOH); {lit. [α]D +6 (c 2.0, MeOH), for
natural (+)-euphococcinine (2) [19]}.
Liebeskind synthesis – 2009
Liebeskind et al. prepared (−)-adaline (1) from the 5-oxo-
pyridinylmolybdenum complex 66 [51]. This complex was de-
veloped as an organometallic enantiomeric scaffold for an
asymmetric construction of a wide variety of heterocyclic
systems.
The synthetic precursor 66 was obtained from furfurylamine
(65), as previously published by the authors [52]. 66 was con-
verted to the (E)-(−)-6-alkylidene-5-oxo 68 through a sequence
of Mukayama aldol–dehydration reactions, via intermediate
anti-aldol (−)-67 (Scheme 8). The addition of Grignard reagent
to the enone (E)-(−)-68 occurred anti to the group TpMo(CO)2
to give adduct (E)-69, which was used in the next step without
purification. The treatment of this adduct with HCl in dioxane
promoted stereospecific semipinacol rearrangement in 78%
yield over two steps. The resulting terminal alkene (−)-70 was
submitted to Vacker's conditions to produce methyl ketone
(−)-71 in 93% yield. The treatment of this ketone with potas-
sium trimethylsilanolate induced a 1,5-Michael type reaction,
via attack of tethered potassium enolate to neutral η3-allyl-
molibdenum.
The crude anionic intermediate 72 was treated with nitroso-
nium hexafluorophosphate in DME to provide bicyclic enone
(−)-73 with 80% yield over two steps. Protection of the non-
conjugated ketone (−)-73 as an acetal derivative occurred selec-
tively to provide enone (−)-74, which was subjected to Luche
reduction followed by removing the resulting alcohol under
Barton–McCombie conditions, providing alkene (−)-75 in 55%
yield from (−)-73. Finally, the acetal group of (+)-75 was
hydrolyzed in the presence of catalytic Pd(MeCN)2Cl2. The
intermediate ketone was subjected to simultaneous catalytic
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Scheme 9: Synthesis of (+)-euphococcinine (2). Reagents and conditions: i) 1. Cp2ZrCl2,AlMe3, CH2Cl2; 2. p-menthyl-3-carboxaldehyde, 9:1 77a/
77b, 67% (after chromatographic separation); ii) butyl vinyl ether, Hg(OAc)2, (10 mol %), sealed tube, 130–135 °C, 79%; iii) vinylmagnesium bromide,
−78 °C; iv) Dess–Martin periodinane, 83% over two steps; v) Grubbs catalyst 2nd gen., CH2Cl2, reflux, 74%; vi) 1. (PhSe)2, NaBH4, EtOH; 2. EtOH/
THF, 99%; vii) 1. O3, CH2Cl2, −78 °C; 2. DMS, −78 °C to rt.; 3. NaClO2, Na2HPO4, t-BuOH/H2O, 2-methy-2-butene, 90%; viii) DPPA, Et3N, toluene,
reflux, 65%; ix) 1. CuCl, H2O/THF, rt to 40 °C; 2. aq K2CO3, rt, 63%.
hydrogenation and hydrogenolysis of the protecting group Cbz
to give (−)-adaline (1) in 90% yield.
The asymmetric synthesis achieved by Liebeskind et al.
presented a high enantiomeric excess and good yields. Also, the
proposed route differed from the previously mentioned in terms
of common intermediaries. Therefore, it’s a new synthesis of
(−)-adaline (1) and might eventually be applied to related
homotropanes. In conclusion, (−)-adaline (1) was obtained in
14 steps from 66 using a new scaffold-based semipinacol/1,5-
Michael-like strategy. The enantiomeric excess for precursor
(−)-75 was 97.6%, determined by HPLC. The overall yield for
this synthesis was 13.4% and specific rotation [α]D25 −13.0
(c 0.73, CHCl3) {lit. [α]D −13 (CHCl3), [17]}.
Spino synthesis – 2009
Spino et al. synthesized both (−)-adaline (1) and (+)-euphococ-
cinine (2) [53]. The main features in this approach consisted of
a 3,3-sigmatropic rearrangement to give an all-carbon quater-
nary center, a ring-closing alkene metathesis to give an 8-mem-
bered ring, and the use of a single enantiomer of p-menthane-3-
carboxaldehyde to make two natural alkaloids of opposite con-
figuration.
Firstly, (+)-euphococcinine (2) was synthesized from terminal
alkyne 76 (Scheme 9). This alkyne was prepared from
5-bromopentene, according to the procedure described by
Negishi [54]. Zr-catalyzed carboalumination furnished vinyl-
alane, treated with p-menthane-3-carboxaldehyde providing the
allylic alcohols (−)-77a and (−)-77b in a 9:1 ratio. After chro-
matographic separation, alcohol (−)-77a, isolated in 67% yield
and >99% de was subjected to a Claisen rearrangement, leading
to aldehyde (−)-78 in 79% yield (96% de determined by
1H NMR). (−)-78 was treated with vinylmagnesium bromide to
give a mixture of allyl alcohols (−)-79a and (−)-79b, which
were oxidized to enone (−)-80. The enone (−)-80 was subjected
to ring-closing metathesis with Grubbs second-generation cata-
lyst resulting in cyclic enone (−)-81 in 74% yield. (−)-81 was
treated with phenylselenol to generate selenide 82 in high yield.
The ozonolysis of 82 was accomplished, followed by the reduc-
tive workup of the resulting selenoxide and an increase in its
temperature, eliminating selenoxide to generate carboxylic acid
(−)-83 in 90% yield. This acid was subjected to Curtius rear-
rangement [55] in the presence of DPPA as a source of azide,
providing isocyanate (−)-84 in 65% yield and complete stereo-
chemistry retention. When isocyanate (−)-84 was treated with
copper chloride in water and THF, the (+)-euphococcinine (2)
was obtained in 63% yield.
A similar sequence was used to synthesize natural (−)-adaline
(1, Scheme 10). In this case, vinyl iodide 86 was obtained from
the carbocupration of 85, a Grignard derivative of 1-heptyne
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Scheme 10: Synthesis of (−)-adaline 1. Reagents and conditions: i) 1. CuBr.DMS, Et2O/DMS, -42 ºC; 2. 1-heptyne; 3. I2, THF, 82%; ii) 1. n-BuLi,
Et2O, −78 °C to 0 °C; 2. p-menthyl-3-carboxaldehyde, 5:1 (−)-87a / (−)-87b, 50% (after chromatographic separation); iii) butyl vinyl ether, Hg(OAc)2,
(10 mol %), sealed tube, 130–135 °C, 79%; iv) vinylmagnesium bromide, −78 °C; v) Dess–Martin periodinane, 83% over two steps; vi) Grubbs cata-
lyst 2nd gen., CH2Cl2, reflux, 74%; vii) 1. (PhSe)2, NaBH4, EtOH; 2. EtOH/THF, 99%; viii) 1. O3, CH2Cl2, −78 °C; 2. DMS, −78 °C to rt; 3. NaClO2,
Na2HPO4, t-BuOH/H2O, 2-methy-2-butene, 90%; ix) DPPA, Et3N, toluene, reflux, 65%; x) 1. CuCl, H2O/THF, rt to 40 °C; 2. aq K2CO3, rt, 63%.
[56]. After a lithium–halogen exchange, the corresponding
vinyllithium was treated with p-menthane-3-carboxaldehyde to
give the isomeric allylalcohols (−)-87a and (−)-87b in a 5:1
ratio. After chromatographic separation, (−)-adaline (1) was ob-
tained from pure (−)-87a, using the same sequence described
previously for (+)-euphococcinine (2) with similar yields.
Through this methodology, (+)-euphococcinine (2) was ob-
tained in 13 steps from 76, in an overall yield of 11.7% and spe-
cific rotation [α]D20 +5.4 (c 0.65, MeOH); {lit. [α]D +7.5
(c 2.0, MeOH), [26]}. Also, (−)-adaline (1) was acessed from
85 in 16 steps, and specific rotation [α]D20 = −11.2 (c = 0.60,
CHCl3); {lit. [α]D –11 (c 2.0, CHCl3), [26]}. It is worth men-
tioning that Spino et al. elegantly proposed a menthol deriva-
tive as a chiral auxiliary for the synthesis of (−)-adaline (1) and
(+)-euphococcinine (2). The cyclooctatetraene derived selenides
82 and (+)-92 are, at some point, similar to the one obtained by
Renbaun in the (−)-adaline (1) synthesis. Renbaun generated the
quaternary center by adding a chiral amine to the cyclooctate-
traene system. On the other hand, Spino et al. firstly made the
quaternary center, followed by cyclization. Furthermore,
Spino's synthesis involved key reactions such as Claisen rear-
rangement, olefin metathesis, and the Curtius rearrangement
that allowed both natural products in good yields.
Davis synthesis – 2010
Davis and Edupuganti prepared the (−)-adaline (1) and the non-
natural isomer (−)-euphococcinine (2) through a four-step intra-
molecular Mannich cyclization cascade reaction [57]. In this
methodology, the alkaloids were prepared by treating the con-
venient N-sulfinylamino ketone ketal precursor on heating with
NH4OAc:HOAc.
Oxo-sulfinimes (+)-95 and (+)-96 were added to a −78 °C solu-
tion of the N-methoxy-N-methylacetamide enolate 102, leading
to Weinreb amides (+)-97 and (+)-98, respectively, with good
yields and high diastereoisomeric excesses (Scheme 11). The
reaction of (+)-97 and (+)-98 with five equivalents of methyl-
magnesium bromide provided ketones (+)-99 and (+)-100, in
diastereoisomeric excess of about 92%. N-sulfinyl-β-aminoke-
tone ketal (+)-99 was subjected to Mannich cyclization, via
treatment with 25 equivalents of ammonium acetate in acetic
acid at 75 °C, generating (−)-euphococcinine (2) in 90% yield.
A similar treatment to ketal (+)-100 provided (−)-adaline (1) in
85% yield.
Ketal (+)-99 was also subjected to the treatment with 3 N
aqueous HCl in MeOH and THF, to provide the homotropane
system directly; however, this reaction led to the piperideine ke-
tone (−)-101 in 86% yield. (−)-101 was also submitted to the
same conditions described previously (25 equiv of ammonium
acetate in 1:1 HOAc/EtOH) to furnish (−)-euphococcinine (2) in
93% yield.
In this work, (−)-euphococcinine (2) and (−)-adaline (1) were
obtained in three steps from oxo-sulfinimes (+)-95 and (+)-96,
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Scheme 11: Synthesis of (−)-euphococcinine (2) and (−)-adaline (1). Reagents and conditions: i) 102, KHMDS, Et2O, −78 °C, 73% (96:4 de;
R = CH3) and 71% (95:5 de; R = n-C5H11); ii) CH3MgBr, −78 °C, THF; 94% (25:1 de; R = CH3) and 95% (22:1 de; R = n-C5H11); iii) NH4OAc/HOAc/
EtOH, 75 °C, 36 h, (90%, R = CH3) and 3.5 days (85%; R = n-C5H11); iv) NH4OAc/HOAc/EtOH, 75 °C, 36 h, 93%; v) 3 N HCl, MeOH, THF, 86%.
Scheme 12: Synthesis of N-methyleuphococcinine 3. Reagents and conditions: i) 108 (1.5 equiv), 3,5-di-F-C6H3B(OH)2 (0.1 equiv), DCE, 50 °C,
18 h, 95%; ii) 1. 1 M HCl, rt, 30 min; 2. PhMe, 100 °C, 10 h, 57% over two steps; iii) MeI, Et2O, 24 h, 73%; iv) Zn, AcOH/THF/H2O, 30 °C, 6 h, 75%;
v) Dess–Martin periodinane, NaHCO3, THF, 0 °C to rt, 58%.
in overall yields of 61.8% and 57.3%, respectively. The conver-
sion of precursors N-sulfinylamino ketone ketals directly to the
desired homotropanes represents a four-step intramolecular
Mannich cyclization cascade reaction, being the most efficient
method to date for the (−)-adaline (1) and (−)-euphococcinine
(2) syntheses. Specific rotation was [α]D20 −6.4 (c 0.83,
MeOH); {lit. [α]D20 −6.5 (c 1.80, MeOH), [26]} for (−)-eupho-
coccinine (2) and [α]D20 −12.6 (c 0.85, CHCl3); {lit. [α]D −13
(CHCl3), [17]} for (−)-adaline (1).
Kurti synthesis – 2020
Kürti et al. developed racemic N-methyleuphococcinine ((±)-3),
exploring the use of arylboronic acids as catalysts for C-allyla-
tion of unprotected oximes with allyl boronates [58].
After screening to find the best reaction conditions, oxime 103
was converted to α-tertiary acetal-protected hydroxylamine
(±)-104 in the presence of 3,5-difluorophenylboronic acid and
diisopropyl allyl boronate (108) in 95% yield after 18 h
(Scheme 12). Hydroxylamine (±)-104 was hydrolyzed in the
presence of aqueous hydrochloric acid, and the resulting nitrone
was heated in toluene to yield the homotropane (±)-105 in 57%
yield over two steps.
(±)-105 was alkylated with excess methyl iodide to form the
corresponding ammonium salt (±)-106 in 73% yield. The N–O
bridge of ammonium salt (±)-106 was reduced with zinc. The
resulting diastereomerically pure amino alcohol (±)-107 was
then oxidized in the presence of Dess–Martin periodinane to
deliver N-methyleuphococcinine ((±)-3).
Although Kurtis' synthesis was racemic, it presented a few steps
and led to N-methyleuphococcinine ((±)-3) in good yields.
Besides, arylboronic acids proved to be efficient catalysts for
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Table 1: Summary of syntheses described in this review.
Synthesis Products Key step Overall yield Number of steps









Meyers [42], 2000 (+)-2 intramolecular Mannich reaction 51.2% from 26 5
Ikeda [45], 2002 (±)-2 precursor Bu3SnH-mediated (radical)
cyclization
14.3% from 34 7
Kibayashi [48],
2002
(−)-1 ring-closing methathesis 28.3% from 43 13
Yu [50], 2009 (−)-1
(−)-2






(−)-1 base-promoted cyclization 13.4% from 66 14
Spino [53], 2009 (+)-2
(−)-1




Davis [57], 2010 (−)-2
(−)-1




Kürti [58], 2020 N-Me-3 termal-promoted cyclization 17.2% from 103 6
the C-allylation of unprotected oximes. Using this method, the
authors accessed the racemic form of N-methyleuphococcinine
(3) in 6 steps with a total yield of 17.2% from oxime 103.
Conclusion
The peculiar structural factors of homotropane alkaloids added
to the intriguing biological activity exerted by ladybirds (as
demonstrated in this review for A. bipunctata), besides the fact
that the insect releases these substances in minimal quantities,
make these targets highly relevant when considering total syn-
thesis. Since Tursch's pioneering work, several total and formal
syntheses of homotropane alkaloids released by coccinellids
have been carried out, contributing to a more accurate chemical
and biological understanding of these alkaloids. Specifically, in
this review, the main points in the synthesis of coccinellid alka-
loids are: i) dipolar cycloaddition; ii) olefin metathesis;
iii) intramolecular Mannich reaction. Cyclization steps, summa-
rized in Table 1, have shown to be efficient in the construction
of an azabicyclononane system and also to provide enantiomeri-
cally pure alkaloids.
Therefore, homotropane-based compounds continue to attract
the attention of researchers involved in the progress for new
synthetic methodologies to reproduce these natural products and
synthesize their analogs, improving existing methods.
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